Australia's TGA reiterates: Nicotine pouches are prescription drugs in Australia, and unapproved products pose safety risks.

Aug.08
Australia's TGA reiterates: Nicotine pouches are prescription drugs in Australia, and unapproved products pose safety risks.
Illegal sale of nicotine pouches in Australia is on the rise, posing health risks and legal consequences.

Key points:

 

·Illegal sales on the rise: The illegal advertising and online sales of nicotine pouches in Australia have increased, with many products coming from overseas and not approved by the Therapeutic Goods Administration (TGA). 

·Legal restrictions: Nicotine pouches are considered prescription drugs in Australia and cannot be sold in retail stores or advertised. 

·Health risks: Nicotine pouches contain high concentrations of nicotine, which can lead to addiction, brain development issues, and various side effects. 

·Legal consequences: Those who violate the law may face up to 5 years in prison and a fine of up to 1.32 million Australian dollars (approximately 860,000 US dollars). 

·Consumer advice: Before purchasing nicotine pouches, make sure to have a prescription or written authorization, and consult a doctor or pharmacist.

 


 

According to the official website of the Therapeutic Goods Administration (TGA) on August 7th, illegal advertisements and online sales of nicotine pouches in Australia have increased, with many of these products being imported from overseas. It is important to note that nicotine pouches are considered prescription drugs in Australia and currently no nicotine pouch products have been approved by the TGA. This means that nicotine pouch products have not undergone safety, quality, and efficacy testing in Australia.

 

Nicotine pouches are small pouches placed between the lips and gums, typically containing varying strengths of nicotine, as well as other ingredients such as sweeteners and flavors. They are often marketed as a "smoke-free" or "tobacco-free" alternative to e-cigarettes. However, there is little evidence to suggest that they are effective in helping people quit smoking or reduce their dependence on nicotine.

 

According to Australian law, nicotine pouches are classified as prescription medications. This means that they:

 

It cannot be sold in retail stores or tobacco shops; advertising is not allowed; it cannot be imported or sold without approval from the TGA or a valid written authorization or prescription from an Australian healthcare practitioner.

 

Some states may have additional restrictions. For example, in South Australia, nicotine pouches are banned under new tobacco and e-cigarette legislation.

 

Violating the law could lead to serious consequences. According to the 1989 Therapeutic Goods Act, significant fines, including up to 5 years imprisonment, a maximum fine of 1.32 million Australian dollars (approximately 860,000 US dollars), or both, may be imposed for illegal advertising and supply activities. Additionally, further fines may be imposed under state and territory medicines and poisons laws.

 

Nicotine pouches can be dangerous. Some nicotine pouches contain high concentrations of nicotine, which may lead to side effects. They are not produced according to Australian standards, and their safety has not been inspected.

 

Nicotine is highly addictive, especially for young people. It may interfere with brain development, affecting memory, learning, and attention.

 

Side effects associated with nicotine pouches include: increased heart rate and high blood pressure; nausea, dizziness, and headaches; mouth ulcers.

 

Some products may not list nicotine on the ingredients label. The lack of clear ingredient information on the label could potentially lead to delayed treatment if the product is ingested, which is especially dangerous for children. Furthermore, mislabeled products are considered counterfeit and should not be imported or supplied under any circumstances.

 

Before purchasing nicotine pouches, make sure you have a prescription or written authorization, and meet all legal requirements. Discuss with your doctor or pharmacist how to properly obtain unapproved medications. Read information from the Therapeutic Goods Administration (TGA) regarding unapproved therapeutic goods.

 

The Therapeutic Goods Administration (TGA) has approved nicotine replacement therapies, including patches, sprays, and lozenges. Unlike nicotine pouches, these products meet Australian quality, safety, and effectiveness standards. They are available for purchase at pharmacies and supermarkets.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
KT&G Q2 earnings: net profit falls 54% to $103 million, NGP revenue down 0.8% to $141 million
KT&G has released its financial report for the second quarter and first half of 2025. The company's first-half revenue surpassed 3 trillion won (approximately US$2.16 billion) for the first time, with second-quarter revenue increasing by 8.7% year-over-year to US$1.114 billion. Net profit decreased by 54.1% year-over-year to US$103 million.
Aug.08 by 2FIRSTS.ai
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
Newport, UK Seizes £6.5 Million Worth of Illegal Goods, Targeting E-Cigarettes and Counterfeit Products
From 2024 to 2025, Newport Trading Standards seized £6.5 million worth of illegal tobacco, e-cigarettes, and counterfeit goods in 41 raids, including 300,000 cigarettes and 12,400 e-cigarette items. The crackdown led to a year-on-year drop in tobacco sales to minors.
Jul.21 by 2FIRSTS.ai
U.K West Yorkshire and Hertfordshire Crack Down on Illegal E-Cigarettes and Tobacco Products
U.K West Yorkshire and Hertfordshire Crack Down on Illegal E-Cigarettes and Tobacco Products
Leeds City Council, West Yorkshire Trading Standards, and police seized large volumes of illegal e-cigarettes and tobacco in a joint operation, shutting down one non-compliant store. Similar actions in Hertfordshire targeted illicit supplies to protect communities and legitimate businesses.
Jul.21 by 2FIRSTS.ai
Scotland E-Cigarette Market Report (3): Nicotine Pouch Sales Up 51% Year-on-Year, Top 5 Brands Capture 97% Market Share
Scotland E-Cigarette Market Report (3): Nicotine Pouch Sales Up 51% Year-on-Year, Top 5 Brands Capture 97% Market Share
Talysis data shows strong growth in oral nicotine sales in Scottish convenience stores pre- and post-ban. By May 2025, market share hit 1.1% (58% growth), rising to 1.3% (51% growth) post-ban. The top five brands capture 97% of sales, with Velo and Nordic leading. UK nicotine pouch sales reached £158 million ($200 million), up 71%, with convenience stores seeing the fastest growth and brands like XQS launching new flavors.
Aug.06 by 2FIRSTS.ai
BAT Questions South Africa’s New Bill: Lack of Distinction Between Cigarettes and E-Cigarettes, Excessive Powers Pose Governance Risks
BAT Questions South Africa’s New Bill: Lack of Distinction Between Cigarettes and E-Cigarettes, Excessive Powers Pose Governance Risks
The South African Parliament is currently reviewing the Tobacco Products and Electronic Delivery Systems Control Bill, which proposes stricter regulation of cigarettes and e-cigarettes. A corporate and regulatory head from British American Tobacco South Africa (BATSA) pointed out that the bill lacks regulatory differentiation, ignores harm-reduction potential, and may weaken the legal market while fueling illicit trade. The company has called on the government to re-evaluate the draft’s content
Aug.18 by 2FIRSTS.ai
American Minneapolis Raises Minimum Price of E-Cigarettes to $25 and Bans New Tobacco Stores Near Schools
American Minneapolis Raises Minimum Price of E-Cigarettes to $25 and Bans New Tobacco Stores Near Schools
The Minneapolis City Council in Minnesota has passed two new tobacco control regulations: raising the minimum price of e-cigarettes to $25 and banning the establishment of new tobacco stores near schools, aiming to reduce youth smoking rates.
Jul.11 by 2FIRSTS.ai